RB

Ravi Bala Goel

Active Director Director DIN 00668417
DIN 00668417 First appointment Feb 1976 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 1976
Shareholding value •••• Premium profile

About Ravi Bala Goel

Data last updated:

Ravi Bala Goel is a Director at Aarge Drugs Pvt Ltd (since 1976). The company operates in Chemicals. Aarge Drugs Pvt Ltd reported revenue of ₹6.8 Lakh (FY 2026).

DIN 00668417
Primary Designation Director
Industry Chemicals
First Appointment 06 Feb 1976
Oldest Company Age 50 yrs
Largest company Aarge Drugs Pvt Ltd · ₹6.8 Lakh (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aarge Drugs Pvt Ltd U24231HP1976PTC003625
Director06 Feb 19761976₹6.8 Lakh (FY 2026)Active

Board colleagues of Ravi Bala Goel

NameDINCompanyDesignation
Ravinder Kumar Goel00668243Aarge Drugs Pvt LtdManaging Director

Directorship timeline

Open interactive timeline →
Aarge Drugs Pvt Ltd
Premium access

Shareholding and investment profile for Ravi Bala Goel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Bala Goel

Ravi Bala Goel currently holds 1 directorship: Aarge Drugs Pvt Ltd (Director, since 06 Feb 1976, revenue ₹6.8 Lakh (FY 2026)).

Ravi Bala Goel was first appointed on 06 Feb 1976 as Director at Aarge Drugs Pvt Ltd.

The current boards of Ravi Bala Goel's companies include Ravinder Kumar Goel (Aarge Drugs Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available